ABCG2 and neoplasm: The overexpression of ABCG2/BCRP in a side population of MCF7-derived cells with stem cell-like features was associated with resistance to mitoxantrone (anthracycline anti-tumor agent used to treat metastatic breast cancer; substrate for ABCG2) [188].